Regional Analysis

Global Infusion Pump Market: Regional Insights

Based on geography, the global infusion pump market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of chronic disease, such as cancer and diabetes, growing geriatric population, increasing demand for infusion pumps, and rise in adoption of smart/portable infusion pumps in the region. For instance, in August 2022, Baxter International Inc. received the U.S. Food and Drug Administration (FDA) 510(k) clearance of its new Novum IQ syringe infusion pump (SYR). Novum IQ SYR utilizes intuitive technologies built to help reduce infusion errors and designed to meet rigorous FDA guidance for infusion devices.

Europe and Asia Pacific are also expected to witness robust growth in the global infusion pump market owing to the rise in burden of chronic disease, growing geriatric population, and increase in adoption of smart/portable infusion pumps in these regions. For instance, with the rise in burden of chronic disease, such as cancer and diabetes, the use or demand for novel infusion pumps is also increasing with the rapid pace. In September 2022, Insulet announced that the Omnipod 5 system received CE mark clearance, making it available throughout the European Union. It’s cleared for use by adults and children aged two and older with type-1 diabetes.

North America: U.S. and Canada
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa